Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls

[1]  U. Ahlfors,et al.  Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression , 1979, Psychopharmacology.

[2]  B. Roos,et al.  5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis , 1972, European Journal of Clinical Pharmacology.

[3]  J. A. Boer,et al.  Handbook of depression and anxiety , 2003 .

[4]  M. Oquendo,et al.  Prolactin Response to dl-Fenfluramine Challenge before and after Treatment with Paroxetine , 2001, Neuropsychopharmacology.

[5]  S. Leucht,et al.  Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[6]  N. Craddock,et al.  Molecular genetics of bipolar disorder , 2001, British Journal of Psychiatry.

[7]  Victoria Arango,et al.  The Neurobiology and Genetics of Suicide and Attempted Suicide: A Focus on the Serotonergic System , 2001, Neuropsychopharmacology.

[8]  J. Rybakowski,et al.  Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. , 2001, Bipolar disorders.

[9]  H. Sackeim,et al.  ECT in bipolar and unipolar depression: differences in speed of response. , 2001, Bipolar disorders.

[10]  W. Drevets.  Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders , 2001, Current Opinion in Neurobiology.

[11]  L. Sher.  Genetic studies of seasonal affective disorder and seasonality. , 2001, Comprehensive psychiatry.

[12]  Tadafumi Kato,et al.  Molecular genetics of bipolar disorder , 1999, Neuroscience Research.

[13]  A. Young,et al.  Bipolar Disorders : Basic Mechanisms and Therapeutic Implications , 2000 .

[14]  M. Fava,et al.  Fenfluramine challenge in unipolar depression with and without anger attacks , 2000, Psychiatry Research.

[15]  J. Potash,et al.  Searching high and low: a review of the genetics of bipolar disorder. , 2000, Bipolar disorders.

[16]  G. MacQueen,et al.  A two-illness model of bipolar disorder. , 1999, Bipolar disorders.

[17]  R. Lam,et al.  Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls. , 1999, Journal of affective disorders.

[18]  John A. Talbott,et al.  The American Psychiatric Press textbook of psychiatry , 1999 .

[19]  R. Murray,et al.  Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response , 1998, Biological Psychiatry.

[20]  E. Coccaro,et al.  Prolactin response to d-fenfluramine in outpatients with major depression , 1998, Psychiatry Research.

[21]  S. Kasper,et al.  Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. , 1998, Archives of general psychiatry.

[22]  L. Siever,et al.  Serotonin, aggression, and parental psychopathology in children with attention-deficit hyperactivity disorder. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  J. Soares,et al.  The anatomy of mood disorders—review of structural neuroimaging studies , 1997, Biological Psychiatry.

[24]  E. Coccaro,et al.  Hormonal Responses to d- and d,l-Fenfluramine in Healthy Human Subjects , 1996, Neuropsychopharmacology.

[25]  T. Dinan,et al.  d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity. , 1996, The American journal of psychiatry.

[26]  R. Murray,et al.  Reduced Prolactin and Cortisol Responses to d-Fenfluramine in Depressed Compared to Healthy Matched Control Subjects , 1996, Neuropsychopharmacology.

[27]  J. Mann,et al.  Prolactin Response to Fenfluramine and Suicide Attempt Lethality in Major Depression , 1996, British Journal of Psychiatry.

[28]  J. Mann,et al.  Blunted Serotonergic Responsivity in Depressed Inpatients , 1995, Neuropsychopharmacology.

[29]  S. Koslow,et al.  Depressive mania versus agitated depression: Biogenic amine and hypothalamic-pituitary-adrenocortical function , 1994, Biological Psychiatry.

[30]  L. Siever,et al.  Familial correlates of reduced central serotonergic system function in patients with personality disorders. , 1994, Archives of general psychiatry.

[31]  S. Kish,et al.  Cerebral cortex β-adrenoceptor binding in bipolar affective disorder , 1994 .

[32]  E. Coccaro,et al.  Neuropsychopharmacologic challenge in biological psychiatry. , 1994, Clinical chemistry.

[33]  L. Yatham,et al.  Neuroendocrine probes of serotonergic function: a critical review. , 1993, Life sciences.

[34]  T. Cooper,et al.  Hormone responses to fenfluramine and placebo challenge in endogenous depression , 1992, Psychiatry Research.

[35]  T. Dinan,et al.  Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.

[36]  G. Mellsop,et al.  Platelet tritiated imipramine binding in patients suffering from mania. , 1991, Journal of affective disorders.

[37]  G. Cassano,et al.  Decreased platelet serotonin uptake in bipolar I patients. , 1991, International clinical psychopharmacology.

[38]  D. Charney,et al.  Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. , 1991, The American journal of psychiatry.

[39]  I. Hickie,et al.  Hormonal Responses to Fenfluramine in Depressive Subtypes , 1990, British Journal of Psychiatry.

[40]  B. Leonard,et al.  Changes in platelet 5-hydroxytryptamine uptake in mania. , 1990, Journal of affective disorders.

[41]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[42]  L. Siever,et al.  Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. , 1989, Archives of general psychiatry.

[43]  J. Sweeney,et al.  Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. , 1989, Archives of general psychiatry.

[44]  Abraham Weizman,et al.  Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients. , 1988, Clinical neuropharmacology.

[45]  Andrew H. Miller,et al.  The neuroendocrine response to fenfluramine in depressives and normal controls , 1988, Biological Psychiatry.

[46]  R. Kahn,et al.  Hormonal probes of central serotonergic activity: Do they really exist? , 1987, Biological Psychiatry.

[47]  Gerald L. Brown,et al.  Human aggression and suicide. , 1986, Suicide & life-threatening behavior.

[48]  M. Åsberg,et al.  Therapeutic effects of serotonin uptake inhibitors in depression. , 1986, The Journal of clinical psychiatry.

[49]  D. A. Lewis,et al.  Tritiated imipramine binding to platelets in manic subjects. , 1985, Journal of affective disorders.

[50]  J C Mazziotta,et al.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. , 1985, Archives of general psychiatry.

[51]  B. Shaywitz,et al.  CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. , 1984, The American journal of psychiatry.

[52]  D. Charney,et al.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. , 1984, Archives of general psychiatry.

[53]  H. Meltzer,et al.  Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. , 1984, Archives of general psychiatry.

[54]  D. Murphy,et al.  Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. , 1984, Life sciences.

[55]  M. Åsberg,et al.  CSF monoamine metabolites in melancholia , 1984, Acta psychiatrica Scandinavica.

[56]  E. Robins,et al.  Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. , 1984, Archives of general psychiatry.

[57]  S. Koslow,et al.  CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. , 1983, Archives of general psychiatry.

[58]  J. Mann,et al.  Altered platelet serotonin uptake kinetics in schizophrenia and depression. , 1982, Life sciences.

[59]  David M. Martin,et al.  DISTINGUISHING UNIPOLAR AND BIPOLAR DEPRESSION BY THYROTROPIN RELEASE TEST , 1979, The Lancet.

[60]  N. Nicolaou,et al.  Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders , 1978, Acta psychiatrica Scandinavica.

[61]  F. Goodwin,et al.  Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites. , 1977, The American journal of psychiatry.

[62]  H. W. Reading,et al.  Memberane ATPase activities in depressive illness , 1977, Journal of neurochemistry.

[63]  C. Bánki.  Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders , 1977, Journal of neurochemistry.

[64]  Ashcroft Gw,et al.  Mood and neuronal functions: a modified amine hypothesis for the etiology of affective illness. , 1974 .

[65]  A. Prange,et al.  L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. , 1974, Archives of general psychiatry.

[66]  F. Goodwin,et al.  Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. , 1973, The American journal of psychiatry.

[67]  P. Whybrow,et al.  Abnormalities of indoleamines in affective disorders. , 1972, Archives of general psychiatry.

[68]  J. Mendels,et al.  Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients , 1972, Science.

[69]  G. Heninger,et al.  Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. , 1969, International journal of neuropharmacology.

[70]  U. Malm,et al.  ACID MONOAMINE METABOLITES OF CEREBROSPINAL FLUID IN MENTAL DEPRESSION AND MANIA , 1966, Journal of neurochemistry.

[71]  J. B. Stanton,et al.  5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. , 1966, Lancet.

[72]  E. Barratt,et al.  Factor Analysis of Some Psychometric Measures of Impulsiveness and Anxiety , 1965, Psychological reports.

[73]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[74]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.